Beone Medicines (6160.HK) traded up 1.69 % during a 24 hours period ending at 12:32 AM Central Europe on Tuesday 27th. One Beone Medicines stock can currently be bought for about HKD 224.4 on popular exchanges. Current supply of Beone Medicines stocks is 1.4 bn. Beone Medicines has a current market capitalization of HKD 337.8 bn and approximately HKD 1 bn worth of Beone Medicines was traded on exchanges in the last 24 hours. Since last month end, Beone Medicines has traded 6.13 % up. Simple moving average of last 200 days is at HKD 194.53. The highest price of past 52 weeks was recorded at HKD 236 on 10/21/2026. 52 weeks low was at HKD 153 on 06/11/2026.

Here is how related stocks have performed in the past 24 hours:

  • Edwards Lifesciences (EW) traded down -1.13 % and now trades at USD 90.56. Current market capitalisation for Edwards Lifesciences is USD 51.3 bn. Current price/earnings ratio for Edwards Lifesciences is 53.45.

  • Agilent (A) traded down -0.47 % and now trades at USD 175.96. Agilent has a market capitalisation of USD 48.8 bn. Current price/earnings ratio for Agilent is 33.9.

  • Workday (WDAY) traded flat 0 % and now trades at USD 208.45. Current market capitalisation for Workday is USD 50.6 bn. Current price/earnings ratio for Workday is 43.33.

  • Humana (HUM) traded up 0.26 % and now trades at USD 417.22. Current market capitalisation for Humana is USD 50.7 bn. Current price/earnings ratio for Humana is 39.96.

About Beone Medicines

BeiGene, Ltd. is a commercial stage biopharmaceutical company specializing in health care with a focus on biotechnology and cancer treatment.